Search
About the network
The main objectives of ERLI-Net are to carry out virological surveillance of human influenza and to ensure that data are shared through the European Influenza Surveillance Network (EISN) reporting mechanisms in a timely manner.
Influenza laboratory quality control
In accordance with the Key Tasks, ERLI-Net laboratories should participate in external quality assurance (EQA) schemes. EQA panels are distributed by both ERLI-Net and the WHO.
Publication
Annual epidemiological report 2011 [2009 data]
Reporting on 2009 surveillance data and 2010 epidemic intelligence data
- Antimicrobial resistance
- Avian influenza virus
- Food- and waterborne diseases
- Healthcare-associated infections
- HIV infection
- Influenza in humans, avian origin
- Influenza in humans, seasonal
- Respiratory diseases
- Sexually transmitted infections
- Surveillance
- Tuberculosis
- Vaccine preventable diseases
- Viral hepatitis
Publication
Annual Epidemiological Report 2012 [2010 data]
The sixth edition of the Annual Epidemiological Report on communicable diseases in Europe provides a comprehensive summary of surveillance data for 2010 and an analysis of the public health threats detected in 2011 through ECDC’s routine epidemic intelligence.
- Antimicrobial resistance
- Avian influenza virus
- Emerging disease
- Food- and waterborne diseases
- HIV infection
- Influenza in humans, avian origin
- Influenza in humans, seasonal
- Legionnaires’ disease
- Sexually transmitted infections
- Surveillance
- Tuberculosis
- Vaccine preventable diseases
- Vector-borne disease
Publication
Annual Epidemiological Report 2010 [2008 data]
The fourth edition of the Annual Epidemiological Report on Communicable Diseases in Europe provides a comprehensive summary of surveillance data for 2008.
- Antimicrobial resistance
- Avian influenza virus
- Emerging disease
- Food- and waterborne diseases
- Healthcare-associated infections
- HIV infection
- Influenza in humans, avian origin
- Influenza in humans, seasonal
- Sexually transmitted infections
- Surveillance
- Tuberculosis
- Vaccine preventable diseases
- Vector-borne disease
Publication
Expert opinion on neuraminidase inhibitors for the prevention and treatment of influenza - review of recent systematic reviews and meta-analyses
This ECDC expert opinion confirms earlier assessments by ECDC and national authorities that there is no significant new evidence to support any changes to the approved indications and recommended use of neuraminidase inhibitors (NAIs) in EU/EEA Member States.
Publication
Influenza virus characterisation, Summary Europe, June 2017
In the course of the 2016–2017 influenza season, nearly 146 000 influenza detections across the EU/EAA region have been reported.
Publication
Influenza virus characterisation, Summary Europe, July 2017
In the course of the 2016–17 influenza season, nearly 146 000 influenza detections have been reported across the WHO European Region.
Publication
Influenza virus characterisation, Summary Europe, September 2017
In the course of the 2016–17 influenza season, over 146 000 influenza detections across the WHO Europe Region have been reported.
Publication
Communicable disease threats report, 10-16 November 2013, week 46
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 10-16 November 2013, and includes updates on avian influenza, cholera, dengue, influenza, MERS, polio and salmonellosis.